1,065.00 USD
↗ 23.35 (2.24%)AT CLOSE (11:59 AM EDT)
Eli Lilly & Co.
LLYNYSE • USD
1,065.00
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1,065.00
↗ 0.00 (0.00%)
Market: CLOSED
Open?$1,049.81
High?$1,070.34
Low?$1,047.07
Prev. Close?$1,041.65
Volume?3.5M
Avg. Volume?3.3M
VWAP?$1,063.09
Rel. Volume?1.05x
Bid / Ask
Bid?$1,064.00 × 80
Ask?$1,066.00 × 80
Spread?$2.00
Midpoint?$1,065.00
Valuation & Ratios
Market Cap?949.7B
Shares Out?941.7M
Float?851.3M
Float %?90.1%
P/E Ratio?37.57
P/B Ratio?30.44
EPS?$28.35
Dividend?0.59%
Ex-Dividend?N/A
Shares of Eli Lilly & Co. (LLY) are trading at $1,065.00. Both sides of the analysis agree: technicals flash "Strong Buy" and fundamentals confirm with a "Buy" reading. This is driven by a robust Altman Z-Score, exceptional Return on Equity (81.0%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, LLY trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of May 22, 2026.
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
949.7B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?83
Short Sent.?84
Piotroski F-Score?6/9Mixed
Altman Z-Score?8.73Safe
Confidence?80%High
Short InterestLow
Short % of Float?0.92%Low
Short Interest?7.9M
Days to Cover?2.2
Free Float851.3M
Avg Daily Volume3.5M
Settlement Date2026-04-30
Financial Health
Current Ratio?1.50Adequate
Quick Ratio?1.10Adequate
Cash Ratio?0.14Low
Debt/Equity?1.39Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?37.6PRICEY▾
Peers20
S&P19
P/B?30.44HIGH▾
Peers10
S&P3
P/S?13.14HIGH▾
Peers20
S&P3
P/FCF?80.3PRICEY▾
Peers10
S&P3
EV/EBITDA?27.3HIGH▾
Peers20
S&P13
EV/Sales?13.67HIGH▾
Peers20
S&P5
Returns & Efficiency
ROE?81.0%STRONG▾
Peers78
S&P97
ROA?21.7%STRONG▾
Peers90
S&P97
Cash Flow & Enterprise
FCF?$11.8B
Enterprise Value?$987.8B
Fundamentals ratios updated end of day